Skip to content
OpenDue May 6, 2026

NOI to Sole Source to QuVa Pharma, Inc.

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Who can apply

No Set aside used. NONE

About this opportunity

The purpose of this acquisition is to purchase 503b compounded Intravenous (IV) Narcotics for patient care. Market research has been conducted with only two responses, from QUVA, the known Compounder and distributor for these IV narcotics. Through trade shows, continuous learning seminars and trade journals, the CC Pharmacy Department stays abreast of the industry and is current on the availability of singular distribution outlets for these medications. � Product Service Code: 6515 � Medical and Surgical Instruments, Equipment, and Supplies � NAICS Code: 325412 � Pharmaceutical Preparation Manufacturing � Place of Performance: NIH Clinical Center, Bethesda, MD 20892 USA POTS: 26-000038 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not ...

Finding similar opportunities...